Intranasal and inhaled fluticasone propionate for pollen‐induced rhinitis and asthma
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Background: Studies suggest that nasal treatment might influence lower airway symptoms and function in patients with comorbid rhinitis and asthma. We investigated the effect of intranasal, inhaled corticosteroid or the combination of both in patients with both pollen‐induced rhinitis and asthma. Methods: A total of 262 patients were randomized to 6 weeks’ treatment with intranasal fluticasone propionate (INFP) 200 μ g o.d., inhaled fluticasone propionate (IHFP) 250 μ g b.i.d., their combination, or intranasal or inhaled placebo, in a multicentre, double‐blind, parallel‐group study. Treatment was started 2 weeks prior to the pollen season and patients recorded their nasal and bronchial symptoms twice daily. Before and after 4 and 6 weeks’ treatment, the patients were assessed for lung function, methacholine responsiveness, and induced sputum cell counts. Results: Intranasal fluticasone propionate significantly increased the percentages of patients reporting no nasal blockage, sneezing, or rhinorrhoea during the pollen season, compared with IHFP or intranasal or inhaled placebo. In contrast, only IHFP significantly improved morning peak‐flow, forced expiratory volume in 1 second (FEV 1) and methacholine PD 20, and the seasonal increase in the sputum eosinophils and methacholine responsiveness. Conclusions: In patients with pollen‐induced rhinitis and asthma, the combination of intranasal and IHFP is needed to control the seasonal increase in nasal and asthmatic symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Allergic Rhinitis and Its Impact on Asthma
Bousquet, J., van Cauwenberge, P., & Khaltaev, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118891 · Cited by 3,588
Corren, J., Adinoff, A. D., Buchmeier, A. D., & Irvin, C. G. (1992) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(92)90079-h · Cited by 290
WELSH, P. W., STRICKER, W. E., CHU, C.-P., NAESSENS, J. M., REESE, M. E., REED, C. E., & MARCOUX, J. P. (1987) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)61882-5 · Cited by 246
(1984) · PubMed · doi:10.1164/arrd.1984.130.6.1014 · Cited by 139
Is antihistamine (H1‐receptor antagonist) therapy useful in clinical asthma?
Simons, F. E. R. (1999) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1999.0290s3098.x · Cited by 53
Cited by
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*
Bousquet, J., Khaltaev, N., Cruz, A. A., Denburg, J., Fokkens, W. J., Togias, A., Zuberbier, T., Baena‐Cagnani, C. E., Canonica, G. W., Van Weel, C., et al. (2008) · Allergy · doi:10.1111/j.1398-9995.2007.01620.x · Cited by 4,729
“The intranasal treatment of rhinitis using glucocorticosteroids was found to improve asthma at best moderately in some but not all studies (2023, 2024).”
Self-citationAllergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
Brożek, J. L., Bousquet, J., Baena-Cagnani, C. E., Bonini, S., Canonica, G. W., Casale, T. B., van Wijk, R. G., Ohta, K., Zuberbier, T., & Schünemann, H. J. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.06.047 · Cited by 1,813
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
Wise, S. K., Lin, S. Y., Toskala, E., Orlandi, R. R., Akdis, C. A., Alt, J. A., Azar, A., Baroody, F. M., Bachert, C., Canonica, G. W., et al. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22073 · Cited by 557
International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Wise, S. K., Damask, C., Roland, L. T., Ebert, C., Levy, J. M., Lin, S., Luong, A., Rodriguez, K., Sedaghat, A. R., Toskala, E., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23090 · Cited by 507
Eifan, A. O., & Durham, S. R. (2016) · Clinical & Experimental Allergy · doi:10.1111/cea.12780 · Cited by 379
Metadata
- Authors
- Dahl, R., Nielsen, L. P., Kips, J., Foresi, A., van Cauwenberge, P., Tudoric, N., Howarth, P., Richards, D. H., Williams, M., Pauwels, R., & the SPIRA Study Group
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 2005-06-02
- Volume
- 60
- Issue
- 7
- Pages
- 875-881
- ISSN
- 0105-4538 (ISSN-L)
- 1398-9995
- OpenAlex
- W1966642551
- Cited by
- 88
- References
- 5
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intranasal and inhaled fluticasone propionate for pollen‐induced rhinitis and asthma. https://app.cochat.ai/papers/10.1111/j.1398-9995.2005.00819.x
- The paper
- Dahl, R., Nielsen, L. P., Kips, J., Foresi, A., van Cauwenberge, P., Tudoric, N., Howarth, P., Richards, D. H., Williams, M., Pauwels, R., & the SPIRA Study Group. (2005). Intranasal and inhaled fluticasone propionate for pollen‐induced rhinitis and asthma. Allergy. https://doi.org/10.1111/j.1398-9995.2005.00819.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.